A Phase-II randomized, double blind, placebo controlled study to assess safety and efficacy of REGEN-D® 10 in treatment of cracked feet - Regen D10

Trial Profile

A Phase-II randomized, double blind, placebo controlled study to assess safety and efficacy of REGEN-D® 10 in treatment of cracked feet - Regen D10

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs Recombinant epidermal growth factor (Primary)
  • Indications Hyperkeratosis
  • Focus Therapeutic Use
  • Sponsors Bharat Biotech
  • Most Recent Events

    • 21 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top